- Home
- ADXN vs PRPO Comparison
ADXN vs PRPO Comparison
Compare ADXN & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- PRPO
- Stock Information
- Founded
- ADXN 2002
- PRPO N/A
- Country
- ADXN Switzerland
- PRPO United States
- Employees
- ADXN N/A
- PRPO N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- ADXN Health Care
- PRPO Industrials
- Exchange
- ADXN Nasdaq
- PRPO Nasdaq
- Market Cap
- ADXN 11.3M
- PRPO 9.6M
- IPO Year
- ADXN N/A
- PRPO N/A
- Fundamental
- Price
- ADXN $10.30
- PRPO $6.70
- Analyst Decision
- ADXN Strong Buy
- PRPO
- Analyst Count
- ADXN 1
- PRPO 0
- Target Price
- ADXN $30.00
- PRPO N/A
- AVG Volume (30 Days)
- ADXN 22.8K
- PRPO 7.7K
- Earning Date
- ADXN 11-11-2024
- PRPO 11-11-2024
- Dividend Yield
- ADXN N/A
- PRPO N/A
- EPS Growth
- ADXN N/A
- PRPO N/A
- EPS
- ADXN 0.05
- PRPO N/A
- Revenue
- ADXN $960,641.00
- PRPO $16,719,999.00
- Revenue This Year
- ADXN N/A
- PRPO $75.18
- Revenue Next Year
- ADXN N/A
- PRPO N/A
- P/E Ratio
- ADXN $1.75
- PRPO N/A
- Revenue Growth
- ADXN N/A
- PRPO 52.61
- 52 Week Low
- ADXN $5.00
- PRPO $4.31
- 52 Week High
- ADXN $27.90
- PRPO $8.99
- Technical
- Relative Strength Index (RSI)
- ADXN 54.08
- PRPO 52.82
- Support Level
- ADXN $10.04
- PRPO $6.42
- Resistance Level
- ADXN $10.81
- PRPO $6.99
- Average True Range (ATR)
- ADXN 0.59
- PRPO 0.33
- MACD
- ADXN 0.04
- PRPO -0.04
- Stochastic Oscillator
- ADXN 70.88
- PRPO 69.91
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.